Salesforce Down Over 5%, on Pace for Largest Percent Decrease Since December 2022 — Data Talk
Salesforce, Inc. (CRM) is currently at $278.69, down $15.63 or 5.31%
--Would be lowest close since Jan. 24, 2024, when it closed at $276.88
--On pace for largest percent decrease since Dec. 5, 2022, when it fell 7.35%
--Currently down five of the past six days
--Currently down four consecutive days; down 7.83% over this period
--Longest losing streak since March 28, 2024, when it fell for five straight trading days
--Worst four day stretch since the four days ending Dec. 8, 2022, when it fell 9.98%
--Down 7.47% month-to-date
--Up 5.91% year-to-date
--Down 12.05% from its all-time closing high of $316.88 on March 1, 2024
--Up 41.41% from 52 weeks ago (April 17, 2023), when it closed at $197.08
--Down 12.05% from its 52-week closing high of $316.88 on March 1, 2024
--Up 46.16% from its 52-week closing low of $190.67 on April 25, 2023
--Traded as low as $278.23; lowest intraday level since Feb. 13, 2024, when it hit $276.42
--Down 5.47% at today's intraday low; largest intraday percent decrease since March 5, 2024, when it fell as much as 5.88%
--Worst performer in the DJIA today
--Worst performer in the S&P 500 today
--Subtracted 102.68 points from the DJIA so far today
All data as of 10:35:32 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 15, 2024 10:53 ET (14:53 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters